The U.S. Consumer Product Safety Commission (CPSC) has warned consumers about using Doraemon Dovfun Suit Magnetic Ball Sets. It has come to light that these products contain loose magnets that pose a significant risk to individuals, especially children.
Reuters reported that seven deaths have already occurred as a result of ingestion.
Non-Compliance With Safety Regulations
According to PR Newswire, CPSC testing has revealed that the magnetic ball sets do not meet the requirements set forth by federal toy regulations. One or more magnets in the sets exceed the permissible strength, and these magnets are of a size that can easily fit within the small parts cylinder as defined by CPSC guidelines.
Potential Dangers and Consequences
After ingestion, the ingested magnets can attract to each other or other metal objects within the digestive system. This can lead to various complications, such as perforations, twisting, blockage of the intestines, infection, blood poisoning, and, in severe cases, death. It is estimated that from 2017 to 2021, approximately 2,400 magnet ingestions were treated in hospital emergency departments in the United States alone.
Inaction From the Seller
Despite a Notice of Violation issued to Doraemon, the Chinese seller of these magnetic ball sets, no action has been taken to address the issue. There is no recall of the product or offer of a remedy to consumers. This lack of response from Doraemon is concerning and raises further alarm about the safety of their products.
The magnetic ball sets were sold online at Amazon.com and were priced at around $25. Each set consisted of multi-colored magnetic balls arranged in a cube shape. These sets were sold encased in a clear plastic case and packaged in a portable tin storage box.
In light of these findings, CPSC urges consumers to cease using the Magnetic Ball Sets immediately, keep them out of reach of children, and properly dispose of them. The risk posed by these hazardous magnets is too high to ignore, and swift action is necessary to prevent further harm.
The Need for Enhanced Safety Measures
The CPSC remains committed to ensuring the safety of consumers and will continue to monitor the situation closely. Furthermore, manufacturers and sellers must prioritize compliance and adherence to safety regulations to protect consumers, particularly vulnerable populations like children.
Photo: PR Newswire


Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
CK Hutchison's Panama Ports Dispute Escalates as Arbitration Claims Surpass $2 Billion
Citi Names Eric Farina and Rob Cascarino to Lead Global Infrastructure Financing Group
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
Google's TurboQuant Algorithm Sends Memory Chip Stocks Tumbling
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
Finnair Orders 18 Embraer E195-E2 Jets in Landmark Fleet Overhaul
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Henkel in Advanced Talks to Acquire Olaplex at $2 Per Share
Rio Tinto's Resolution Copper Mine: U.S. Smelting Challenges and Global Operations Update
Goldman Sachs Raises ECB Rate Hike Forecast Amid Persistent Energy-Driven Inflation
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 



